The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Jan Hedenbro

Jan Hedenbro

Visiting research fellow

Jan Hedenbro

Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels


  • Andreas Lindqvist
  • Mikael Ekelund
  • Stefan Pierzynowski
  • Leif Groop
  • Jan Hedenbro
  • Nils Wierup

Summary, in English

Gastric bypass surgery results in remission of type 2 diabetes in the majority of patients. The incretin hormones glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) have been implicated in the observed remission. Most knowledge so far has been generated in obese subjects. To isolate the surgical effects of gastric bypass on metabolism and hormone responses from the confounding influence of obesity, T2D, or food intake, we performed gastric bypass in lean pigs, using sham-operated and pair-fed pigs as controls. Thus, pigs were subjected to Roux-en-Y gastric bypass (RYGB) or sham surgery and oral glucose tolerance tests (OGTT). RYGB pigs and sham pigs exhibited similar basal and 120-min glucose levels in response to the OGTT. However, RYGB pigs had approximately 1.6-fold higher 30-min glucose (p < 0.01). Early insulin release (EIR) was enhanced approximately 3.5-fold in the RYGB pigs (p < 0.01). Furthermore, GIP release, both acute and sustained release (p < 0.001 and p < 0.01, respectively), was increased approximately 2.5-fold and 1.4-fold, respectively, in RYGB pigs. Although total GLP-1 release increased approximately 2.1-fold after RYGB (p < 0.001), active GLP-1 was 33% lower (p < 0.01). Interestingly basal DPP4-activity was approximately 3.2-fold higher in RYGB pigs (p < 0.001). In conclusion, RYGB in lean pigs increases the response of GIP, total GLP-1, and insulin, but reduces levels of active GLP-1 in response to an oral glucose load. These data challenge the role of active GLP-1 as a contributor to remission from diabetes after RYGB.


  • Neuroendocrine Cell Biology
  • Surgery (Lund)
  • Functional zoology
  • Genomics, Diabetes and Endocrinology
  • EXODIAB: Excellence of Diabetes Research in Sweden

Publishing year










Document type

Journal article




  • Cell and Molecular Biology


  • Bariatric surgery
  • Gastric Bypass
  • GIP
  • GLP-1
  • Insulin
  • Pig model



Research group

  • Neuroendocrine Cell Biology
  • Genomics, Diabetes and Endocrinology


  • ISSN: 0196-9781